World's Best Scientists 2026 revealed!
José M. Gatell

José M. Gatell

Award Badge
Microbiology
Spain
2026

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 98 451 404 9 9 533 41092
Medicine 98 8825 8283 126 123 572 42661

José M. Gatell publications per year

The chart shows the history of publications by José M. Gatell between 1976 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. José M. Gatell published across 50 years, from 1976 to 2025, averaging 11.6 papers a year. Output peaked at 39 publications in 2007. 4 of the 582 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1976 to 2025. Vertical axis: number of publications, 0 to 39. Peak 39 publications in 2007. 1976: 1 publication 1977: 0 publications 1978: 0 publications 1979: 0 publications 1980: 0 publications 1981: 1 publication 1982: 4 publications 1983: 1 publication 1984: 3 publications 1985: 3 publications 1986: 3 publications 1987: 5 publications 1988: 5 publications 1989: 5 publications 1990: 3 publications 1991: 7 publications 1992: 3 publications 1993: 5 publications 1994: 4 publications 1995: 8 publications 1996: 7 publications 1997: 6 publications 1998: 12 publications 1999: 9 publications 2000: 11 publications 2001: 15 publications 2002: 22 publications 2003: 14 publications 2004: 28 publications 2005: 27 publications 2006: 23 publications 2007: 39 publications 2008: 31 publications 2009: 26 publications 2010: 22 publications 2011: 33 publications 2012: 29 publications 2013: 26 publications 2014: 25 publications 2015: 26 publications 2016: 20 publications 2017: 19 publications 2018: 18 publications 2019: 18 publications 2020: 1 publication 2021: 6 publications 2022: 2 publications 2023: 2 publications 2024: 1 publication 2025: 3 publications
1976 2025

582 publications in total across all disciplines

View publications per year as a table
José M. Gatell: publications per year, 1976 to 2025
Year Publications
1976 1
1977 0
1978 0
1979 0
1980 0
1981 1
1982 4
1983 1
1984 3
1985 3
1986 3
1987 5
1988 5
1989 5
1990 3
1991 7
1992 3
1993 5
1994 4
1995 8
1996 7
1997 6
1998 12
1999 9
2000 11
2001 15
2002 22
2003 14
2004 28
2005 27
2006 23
2007 39
2008 31
2009 26
2010 22
2011 33
2012 29
2013 26
2014 25
2015 26
2016 20
2017 19
2018 18
2019 18
2020 1
2021 6
2022 2
2023 2
2024 1
2025 3
Total 582
Download as CSV

José M. Gatell publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where José M. Gatell sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 525–534 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 533 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155
235–244 161
245–254 160
255–264 146
265–274 139
275–284 148
285–294 115
295–304 96
305–314 88
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14 533
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

José M. Gatell D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where José M. Gatell sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 98 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 98 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30
41 86
42 90
43 117
44 122
45 123
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127
54 134
55 134
56 112
57 136
58 162
59 151
60 139
61 123
62 126
63 144
64 109
65 103
66 124
67 112
68 103
69 131
70 94
71 93
72 96
73 92
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21 98
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Microbiology in Spain Leader Award
  • 2025 - Research.com Microbiology in Spain Leader Award

Overview

José M. Gatell is affiliated with the University of Barcelona in Spain. Their research primarily focuses on fields within medicine, particularly immunology and microbiology, with a significant emphasis on infectious diseases. They have contributed extensively to the study of HIV/AIDS, including drug development, treatment, and related health complications.

Their research topics include:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV-related health complications and treatments
  • HIV/AIDS Research and Interventions
  • Pharmacological Effects and Toxicity Studies
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Immune Cell Function and Interaction

José M. Gatell has published papers across a variety of journals and venues. Frequent publication venues include:

  • UNC Libraries
  • Journal of Antimicrobial Chemotherapy
  • The Lancet HIV
  • Clinical Infectious Diseases
  • AIDS Research and Human Retroviruses

Notable recent papers authored or co-authored by José M. Gatell include:

  • Antiretroviral Treatment of Adult HIV Infection 2008 Recommendations of the International AIDS Society-USA Panel, 2020, UNC Libraries
  • Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial, 2021, The Lancet HIV
  • Immunological and virological findings in a patient with exceptional post-treatment control: a case report, 2022, The Lancet HIV
  • Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial, 2023, Clinical Infectious Diseases
  • Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease, 2020, Journal of Antimicrobial Chemotherapy

Throughout their career, José M. Gatell has frequently collaborated with several co-authors. These include:

  • Peré Domingo
  • Bonaventura Clotet
  • Estebán Martínez
  • Christoph Stephan
  • Elisa de Lazzari

Their work spans numerous subfields in medicine such as infectious diseases, virology, emergency medicine, pediatrics, perinatology and child health, and epidemiology, reflecting a broad scope of study within clinical and therapeutic contexts.

Best Publications

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel

    Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner

  • Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

    Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper

  • Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

    Roy T. Steigbigel;David A. Cooper;Princy N. Kumar;Joseph E. Eron

  • Antiretroviral therapy for HIV infection. A knowledge-based approach to drug selection and use.

    Graeme J. Moyle;Brian G. Gazzard;David A. Cooper;José Gatell

  • Antiretroviral Treatment of Adult HIV Infection

    Scott M. Hammer;Joseph J. Eron;Peter Reiss;Robert T. Schooley

  • Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

    Patrick G. Yeni;Scott M. Hammer;Martin S. Hirsch;Michael S. Saag

  • Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

    Beatriz Grinsztejn;Bach Yen Nguyen;Christine Katlama;Jose M. Gatell

  • Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation.

    A Torres;J M Gatell;E Aznar;M el-Ebiary

  • HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

    Maria J Buzón;Marta Massanella;Josep M Llibre;Anna Esteve

  • Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.

    David A. Cooper;Roy T. Steigbigel;Jose M. Gatell;Jurgen K. Rockstroh

  • Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

    Sean Emery;Jacqueline A. Neuhaus;Andrew N. Phillips;Abdel Babiker

  • Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study

    Esteban Martínez;Amanda Mocroft;Miguel A García-Viejo;José B Pérez-Cuevas

  • Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.

    Amanda Mocroft;Ole Kirk;Peter Reiss;Stephane De Wit

  • Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

    François Raffi;Hans Jaeger;Eugenia Quiros-Roldan;Helmut Albrecht

  • Beyond viral suppression of HIV – the new quality of life frontier

    Jeffrey V. Lazarus;Jeffrey V. Lazarus;Kelly Safreed-Harmon;Simon E. Barton;Dominique Costagliola

  • Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.

    Esteban Martinez;José L. Blanco;Juan A. Arnaiz;José B. Perez-Cuevas

  • Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    Unknown

  • Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.

    Kathleen Squires;Adriano Lazzarin;José M. Gatell;William G. Powderly

  • Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.

    Esteban Martínez;Juan A. Arnaiz;Daniel Podzamczer;David Dalmau

  • Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

    Joseph J. Eron;Bonaventura Clotet;Jacques Durant;Christine Katlama

Frequent Co-Authors

Felipe García
Felipe García University of Barcelona
José M. Miró
José M. Miró University of Barcelona
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Josep Mallolas
Josep Mallolas University of Barcelona
Tomás Pumarola
Tomás Pumarola Vall d'Hebron Institut de Recerca
Amanda Mocroft
Amanda Mocroft University College London
Pere Domingo
Pere Domingo Autonomous University of Barcelona
Peter Reiss
Peter Reiss University of Amsterdam
Andrew N. Phillips
Andrew N. Phillips University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to microbiology can open doors to diverse career paths in health and science fields. For instance, becoming a certified child life specialist offers rewarding opportunities supporting children through medical experiences. Understanding a certified child life specialist salary can help students gauge the financial benefits alongside their passion for care.

Many students face unique challenges when pursuing education, including those with legal histories. Fortunately, several degrees felons can get provide a pathway to meaningful careers, demonstrating that academic advancement remains accessible and achievable.

The healthcare sector also offers specialized roles like the functional medicine nurse practitioner, blending traditional and holistic practices. Learning about the functional medicine nurse salary helps prospective students assess financial prospects in this growing field.

For those interested in medical administration, pursuing certification as a professional coder is another viable career route. Information regarding the certified professional coder salary highlights earning potential and job stability within healthcare coding and billing.

Best Scientists Citing José M. Gatell

Trending Scientists

Recently Published Articles